These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 11345391)

  • 1. Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pigs with chronic experimental myocardial ischemia.
    Fuchs S; Baffour R; Zhou YF; Shou M; Pierre A; Tio FO; Weissman NJ; Leon MB; Epstein SE; Kornowski R
    J Am Coll Cardiol; 2001 May; 37(6):1726-32. PubMed ID: 11345391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intramyocardial gene therapy with naked DNA encoding vascular endothelial growth factor improves collateral flow to ischemic myocardium.
    Tio RA; Tkebuchava T; Scheuermann TH; Lebherz C; Magner M; Kearny M; Esakof DD; Isner JM; Symes JF
    Hum Gene Ther; 1999 Dec; 10(18):2953-60. PubMed ID: 10609656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines.
    Kamihata H; Matsubara H; Nishiue T; Fujiyama S; Tsutsumi Y; Ozono R; Masaki H; Mori Y; Iba O; Tateishi E; Kosaki A; Shintani S; Murohara T; Imaizumi T; Iwasaka T
    Circulation; 2001 Aug; 104(9):1046-52. PubMed ID: 11524400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular endothelial growth factor C-induced collateral formation in a model of myocardial ischemia.
    Pätilä T; Ikonen T; Rutanen J; Ahonen A; Lommi J; Lappalainen K; Krogerus L; Ihlberg L; Partanen TA; Lähteenoja L; Virtanen K; Alitalo K; Ylä-Herttuala S; Harjula A
    J Heart Lung Transplant; 2006 Feb; 25(2):206-13. PubMed ID: 16446222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electromagnetic guidance for catheter-based transendocardial injection: a platform for intramyocardial angiogenesis therapy. Results in normal and ischemic porcine models.
    Kornowski R; Leon MB; Fuchs S; Vodovotz Y; Flynn MA; Gordon DA; Pierre A; Kovesdi I; Keiser JA; Epstein SE
    J Am Coll Cardiol; 2000 Mar; 35(4):1031-9. PubMed ID: 10732905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biologic bypass with the use of adenovirus-mediated gene transfer of the complementary deoxyribonucleic acid for vascular endothelial growth factor 121 improves myocardial perfusion and function in the ischemic porcine heart.
    Mack CA; Patel SR; Schwarz EA; Zanzonico P; Hahn RT; Ilercil A; Devereux RB; Goldsmith SJ; Christian TF; Sanborn TA; Kovesdi I; Hackett N; Isom OW; Crystal RG; Rosengart TK
    J Thorac Cardiovasc Surg; 1998 Jan; 115(1):168-76; discussion 176-7. PubMed ID: 9451061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement of cardiac function by bone marrow cell implantation in a rat hypoperfusion heart model.
    Nishida M; Li TS; Hirata K; Yano M; Matsuzaki M; Hamano K
    Ann Thorac Surg; 2003 Mar; 75(3):768-73; discussion 773-4. PubMed ID: 12645691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of therapeutic angiogenesis from direct myocardial administration of an adenoviral vector expressing vascular endothelial growth factor 165.
    Zhang D; Gai L; Fan R; Dong W; Wen Y
    Chin Med J (Engl); 2002 May; 115(5):643-8. PubMed ID: 12133527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A strategy of retrograde injection of bone marrow mononuclear cells into the myocardium for the treatment of ischemic heart disease.
    Yokoyama S; Fukuda N; Li Y; Hagikura K; Takayama T; Kunimoto S; Honye J; Saito S; Wada M; Satomi A; Kato M; Mugishima H; Kusumi Y; Mitsumata M; Murohara T
    J Mol Cell Cardiol; 2006 Jan; 40(1):24-34. PubMed ID: 16271723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs.
    Banai S; Jaklitsch MT; Shou M; Lazarous DF; Scheinowitz M; Biro S; Epstein SE; Unger EF
    Circulation; 1994 May; 89(5):2183-9. PubMed ID: 7514110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VEGF administration in chronic myocardial ischemia in pigs.
    Lopez JJ; Laham RJ; Stamler A; Pearlman JD; Bunting S; Kaplan A; Carrozza JP; Sellke FW; Simons M
    Cardiovasc Res; 1998 Nov; 40(2):272-81. PubMed ID: 9893720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VEGF improves myocardial blood flow but produces EDRF-mediated hypotension in porcine hearts.
    Hariawala MD; Horowitz JR; Esakof D; Sheriff DD; Walter DH; Keyt B; Isner JM; Symes JF
    J Surg Res; 1996 Jun; 63(1):77-82. PubMed ID: 8661176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transmyocardial laser revascularization combined with vascular endothelial growth factor 121 (VEGF121) gene therapy for chronic myocardial ischemia--do the effects really add up?
    Heilmann CA; Attmann T; von Samson P; Göbel H; Marmé D; Beyersdorf F; Lutter G
    Eur J Cardiothorac Surg; 2003 Jan; 23(1):74-80. PubMed ID: 12493508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transepicardial autologous bone marrow-derived mononuclear cell therapy in a porcine model of chronically infarcted myocardium.
    Waksman R; Fournadjiev J; Baffour R; Pakala R; Hellinga D; Leborgne L; Yazdi H; Cheneau E; Wolfram R; Seabron R; Horton K; Kolodgie F; Virmani R; Rivera E
    Cardiovasc Radiat Med; 2004; 5(3):125-31. PubMed ID: 15721847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement of collateral perfusion and regional function by implantation of peripheral blood mononuclear cells into ischemic hibernating myocardium.
    Kamihata H; Matsubara H; Nishiue T; Fujiyama S; Amano K; Iba O; Imada T; Iwasaka T
    Arterioscler Thromb Vasc Biol; 2002 Nov; 22(11):1804-10. PubMed ID: 12426208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arteriogenesis induced by intramyocardial vascular endothelial growth factor 165 gene transfer in chronically ischemic pigs.
    Crottogini A; Meckert PC; Vera Janavel G; Lascano E; Negroni J; Del Valle H; Dulbecco E; Werba P; Cuniberti L; Martínez V; De Lorenzi A; Telayna J; Mele A; Fernández JL; Marangunich L; Criscuolo M; Capogrossi MC; Laguens R
    Hum Gene Ther; 2003 Sep; 14(14):1307-18. PubMed ID: 14503966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and feasibility of transendocardial autologous bone marrow cell transplantation in patients with advanced heart disease.
    Fuchs S; Kornowski R; Weisz G; Satler LF; Smits PC; Okubagzi P; Baffour R; Aggarwal A; Weissman NJ; Cerqueira M; Waksman R; Serrruys P; Battler A; Moses JW; Leon MB; Epstein SE
    Am J Cardiol; 2006 Mar; 97(6):823-9. PubMed ID: 16516583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of intramyocardial injection of autologous bone marrow-derived mononuclear cells on perfusion, function, and viability in patients with drug-refractory chronic ischemia.
    Beeres SL; Bax JJ; Dibbets P; Stokkel MP; Zeppenfeld K; Fibbe WE; van der Wall EE; Schalij MJ; Atsma DE
    J Nucl Med; 2006 Apr; 47(4):574-80. PubMed ID: 16595489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Focal angiogen therapy using intramyocardial delivery of an adenovirus vector coding for vascular endothelial growth factor 121.
    Lee LY; Patel SR; Hackett NR; Mack CA; Polce DR; El-Sawy T; Hachamovitch R; Zanzonico P; Sanborn TA; Parikh M; Isom OW; Crystal RG; Rosengart TK
    Ann Thorac Surg; 2000 Jan; 69(1):14-23; discussion 23-4. PubMed ID: 10654479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of correlation between angiographic grading of collateral and myocardial perfusion and function: implications for the assessment of angiogenic response.
    Fuchs S; Shou M; Baffour R; Epstein SE; Kornowski R
    Coron Artery Dis; 2001 May; 12(3):173-8. PubMed ID: 11352073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.